Utilization of Cardiac Magnetic Resonance Imaging for Assessing Myocardial Fibrosis in Prognosis Evaluation and Risk Stratification of Patients with Dilated Cardiomyopathy

Utilization of Cardiac Magnetic Resonance Imaging for Assessing Myocardial Fibrosis in Prognosis Evaluation and Risk Stratification of Patients with Dilated Cardiomyopathy

Dilated cardiomyopathy (DCM) is the ultimate manifestation of the myocardial response to various genetic and environmental changes and is characterized mainly by impaired left ventricular systolic and diastolic function. DCM can ultimately lead to heart failure, ventricular arrhythmia (VA), and sudd...

Full description

Saved in:

Bibliographic Details
Main Authors:	Xin-Yi Feng, Yu-Cong Zheng, Ying-Xia Yang, Wen-Feng He, Fan Yang, Ling-Li Wang, Han-Feng Yang, Chun-Ping Li, Xiao-Xue Xu, Rui Li
Format:	Article
Language:	English
Published:	IMR Press 2025-01-01
Series:	Reviews in Cardiovascular Medicine
Subjects:	cardiac magnetic resonance dilated cardiomyopathy myocardial fibrosis late gadolinium enhancement t1 mapping imaging prognosis
Online Access:	https://www.imrpress.com/journal/RCM/26/1/10.31083/RCM25654
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

BMP6, a potential biomarker of inflammatory fibrosis and promising protective factor for dilated cardiomyopathy
by: Feng Jiang, et al.
Published: (2025-01-01)

Changes in clinical and imaging variables during withdrawal of heart failure therapy in recovered dilated cardiomyopathy
by: Brian P. Halliday, et al.
Published: (2022-06-01)

Role of Cardiac Magnetic Resonance Imaging in Detecting Myocardial Viability in Patients with Chronic Ischaemic Heart Disease: A Prospective Observational Study
by: Subhosree Dey, et al.
Published: (2025-01-01)

Genotype-phenotype insights of pediatric dilated cardiomyopathy
by: Ying Dai, et al.
Published: (2025-01-01)

Outcome and prognostic value of N‐terminal pro‐brain natriuretic peptide and high‐sensitivity C‐reactive protein in mildly dilated cardiomyopathy vs. dilated cardiomyopathy
by: Jiayu Feng, et al.
Published: (2022-06-01)

Dilated cardiomyopathy signature metabolic marker screening: Machine learning and multi-omics analysis
by: Xiao-Lei Li, et al.
Published: (2025-02-01)

Impact of cardiac magnetic resonance on the diagnosis and management of patients with cardiomyopathies
by: Popa Oana-Andreea, et al.
Published: (2024-09-01)

Layer-Specific Strain Analysis in Patients with Dilated Cardiomyopathy
by: Despina-Manuela Toader, et al.
Published: (2024-12-01)

Effects of genetic mutations on left ventricular myocardial mechanics and fibrosis patterns in hypertrophic cardiomyopathy
by: Minjeong Kim, et al.
Published: (2025-01-01)

Impaired hemodynamic forces assessed by routine CMR and its determinants in different duration T2DM patients with normal LV function and myocardial strain
by: Guozhu Shao, et al.
Published: (2025-01-01)

Inhibition of high glucose-induced cardiac fibroblast activation: an effective treatment for diabetic cardiomyopathy using Chinese herbal medicine
by: Bin Wan, et al.
Published: (2025-01-01)

Anesthetic Management of a Patient with Dilated Cardiomyopathy Undergoing Cerebral Aneurysm Clipping Surgery: A Case Report
by: Navneh Samagh, et al.

Genetic Polymorphism in Peripartum Cardiomyopathy
by: Ivana Purnama Dewi, et al.
Published: (2021-12-01)

PET-CT Imaging in Hypertrophic Cardiomyopathy: A Narrative Review on Risk Stratification and Prognosis
by: Patrícia Marques-Alves, et al.
Published: (2025-01-01)

Isoproterenol mechanisms in inducing myocardial fibrosis and its application as an experimental model for the evaluation of therapeutic potential of phytochemicals and pharmaceuticals
by: Lujain Bader Eddin, et al.
Published: (2025-01-01)

Advantages of using T1-mapping in cardiac magnetic resonance imaging in patients with acromegaly
by: Alina A. Almaskhanova, et al.
Published: (2024-12-01)

Baricitinib represses the myocardial fibrosis via blocking JAK/STAT and TGF-β1 pathways in vivo and in vitro
by: Renlei Feng, et al.
Published: (2025-01-01)

TAB2 deficiency induces dilated cardiomyopathy by promoting mitochondrial calcium overload in human iPSC-derived cardiomyocytes
by: Wenrui Sun, et al.
Published: (2025-02-01)

Intrapericardial injection of hydrogels with ASC and their secretome to treat dilated cardiomyopathies
by: Tácia Tavares Aquinas Liguori, et al.
Published: (2025-01-01)

Adhered macrophages as an additional marker of cardiomyocyte injury in biopsies of patients with dilated cardiomyopathy
by: Warmusz Oliwia, et al.
Published: (2025-02-01)

Pitavastatin-attenuated cardiac dysfunction in mice with dilated cardiomyopathy via regulation of myocardial calcium handling proteins
by: Hu Wei, et al.
Published: (2014-03-01)

Contribution of hypoxia-inducible factor 1alpha to pathogenesis of sarcomeric hypertrophic cardiomyopathy
by: Sarala Raj Murthi, et al.
Published: (2025-01-01)

Impairment of myocardial perfusion correlates with heart failure severity in patients with non‐compaction cardiomyopathy
by: Andraz Cerar, et al.
Published: (2020-06-01)

The influence of HIV infection on myocardial fibrosis diagnosed by cardiac magnetic resonance imaging in adults: a systematic review and meta-analysis of observation studies
by: Katongo Hope Mutengo, et al.
Published: (2025-01-01)

Hypocalcaemic cardiomyopathy: a description of two cases and a literature review
by: Martin Válek, et al.
Published: (2020-06-01)

Extracellular volume fraction and native T1 mapping in diabetic cardiomyopathy: a comprehensive meta-analysis
by: Ahmed Marey, et al.
Published: (2025-02-01)

Identifying etiologies of heart failure using non-contrast cardiac magnetic resonance imaging: cine imaging, T1 and T2 mapping, and texture analysis for T1 mapping
by: Yasuo Amano, et al.
Published: (2025-01-01)

The Effect of Coronary Artery Disease on the Prognosis of Hypertrophic Cardiomyopathy: A Multi-Center Cohort Study
by: Guoqing Hou, et al.
Published: (2025-01-01)

SOX9: a key transcriptional regulator in organ fibrosis
by: Yishuo Li, et al.
Published: (2025-02-01)

Impact of exercise-based cardiac rehabilitation on cardiopulmonary function and prognosis in ST elevation myocardial infarction after PCI patients in extremely cold regions
by: Shenglong Hou, et al.
Published: (2025-02-01)

Three-dimensional Feature Tracking Cardiac Magnetic Resonance in Hypertrophic Cardiomyopathy: Comparison with Two-Dimensional Algorithm
by: Tomoaia Raluca, et al.
Published: (2024-12-01)

Early Myocardial Strain Reduction and miR-122-5p Elevation Associated with Interstitial Fibrosis in Anthracycline-Induced Cardiotoxicity
by: María de Regla Caballero-Valderrama, et al.
Published: (2024-12-01)

Idiopathic pulmonary fibrosis is a risk factor for cardiovascular disease: potential role of KL-6 and systemic inflammation
by: Mohamed F. AbdelGhany, et al.
Published: (2025-01-01)

A note on dilations and martingales
by: Martin L. Jones
Published: (1993-01-01)

Primary Terminal Haemochromatosis in a 50 Year-Old Patient
by: M. I. Gonik, et al.
Published: (2021-04-01)

Autograft dilation after Ross procedure in children and young adults is mitigated by autograft reinforcement: A retrospective MRI study
by: Raphael Seiler, et al.
Published: (2025-01-01)

The design and rationale of the cardiac REHABilitation to improve metabolic health in Hypertrophic CardioMyopathy (REHAB-HCM) Study
by: Matthew Cheung, et al.
Published: (2025-02-01)

MicroRNA-26b inhibits cardiac remodeling after myocardial infarction by targeting ring finger protein 6 expression
by: Chun-Mei Tang, et al.
Published: (2021-04-01)

Mechanism of mTOR/RILP-regulated autophagic flux in increased susceptibility to myocardial ischemia-reperfusion in diabetic mice
by: Jiyao Zhao, et al.
Published: (2025-01-01)

Racial differences in takotsubo cardiomyopathy outcomes in a large nationwide sample
by: Raja Zaghlol, et al.
Published: (2020-06-01)